Teplizumab: Can We Delay the Onset of Type 1?

This content originally appeared on diaTribe. Republished with permission. By Dr. Francine Kaufman Provention Bio’s new injectable drug was recommended by an FDA committee for approval on May 25, 2021. Studies show that teplizumab can delay, for people at risk for type 1, the onset of the condition for two years or more. Learn what […]